Dr. Tyna Moore Explains Microdosing GLP-1s for Appetite Control and Muscle Preservation
In a recent episode of the Ben Greenfield Life podcast, Dr. Tyna Moore revisits the topic of GLP-1 medications, which have been a subject of much debate and misunderstanding. Dr. Moore was among the early advocates for using these drugs at low doses, emphasizing their potential benefits while addressing the prevalent concerns surrounding them. Many people have expressed fears about muscle wasting and other side effects, often referred to as 'Ozempic face' and suicidality. However, Dr. Moore presents a different perspective, suggesting that much of the criticism may be overstated.
During their discussion, Dr. Greenfield shared his personal experience with microdosing semaglutide, a common GLP-1 medication. He noted that after injecting just one-tenth of the standard dose, he found it challenging to consume a regular meal, indicating the potency of even a small amount. Dr. Moore elaborated on appropriate dosing strategies aimed at appetite control rather than outright suppression, which can lead to better outcomes for those looking to manage their weight effectively.
The conversation also touched on the thyroid cancer black box warning associated with GLP-1 drugs, clarifying the basis of these warnings and how they relate to the broader context of GLP-1 usage. Dr. Moore explained that the concerns about suicidality stem from a specific study that measured different variables, which may not directly correlate with the general population's experience.
Furthermore, Dr. Moore highlighted the importance of protecting muscle mass while using GLP-1 medications, a critical consideration for anyone looking to maintain their physical health during weight management efforts. She also mentioned her transition away from taking new patients, directing listeners to her community, The Menopause Rebellion, which focuses on issues pertinent to Gen X women, including hormones, metabolism, and the use of GLP-1s and peptides.
As the conversation wrapped up, listeners were encouraged to consider the nuanced information surrounding GLP-1 medications, urging them to consult with healthcare professionals to navigate their options safely and effectively. This discussion serves as a reminder of the complexities involved in modern weight management strategies and the importance of informed decision-making.




